U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2022, Business and Industry Statistics

U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2022

Filed*

Q1

Q2

Q3

Q4

Cumulative

NDAs

21a

22b

21c

31

96

BLAs

7

5

10d

15

37

Total

27

28

34

46

133

Approved

Q1

Q2

Q3

Q4

Cumulative



A Representative List of Organizations that Have Used our Research and Products: